Wardwizard Healthcare Limited has announced the resignation of its Chief Financial Officer, Ms. Mittalben Patel, effective from the closure of business hours on March 30, 2026. The company communicated this development to BSE Limited on March 16, 2026, in compliance with regulatory requirements.

Resignation Details

Ms. Mittalben Patel, who served as the Chief Financial Officer and Key Managerial Personnel of the company, submitted her resignation letter dated March 16, 2026. The resignation becomes effective from March 30, 2026, marking the end of her tenure with the organization.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has provided all requisite details as prescribed under the Listing Regulations in accordance with SEBI Circular No.HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.

Reasons for Departure

In her resignation letter, Ms. Patel stated that her decision was driven by personal growth aspirations and the desire to pursue new professional opportunities. She expressed her sincere gratitude to the Board of Directors for their support and cooperation during her tenure with the company.

Company Response

The Board of Directors has acknowledged the resignation and expressed their appreciation for Ms. Patel's contributions during her service period. The company has confirmed that there are no other material reasons for the resignation beyond those explicitly stated by the departing CFO. The Board has wished her continued success and the very best for all her future endeavors.

Administrative Actions

Wardwizard Healthcare Limited, formerly known as Ayoki Merchantile Limited, has made the resignation information available on its official website at www.ayokimerchantile.com . The company will file the necessary e-forms with the Registrar of Companies as required under the Companies Act 2013 and make appropriate disclosures to stock exchanges as mandated by regulatory frameworks.

Wardwizard healthcare Limited's Board of Directors held a meeting on February 12, 2026, to discuss significant compliance issues related to SEBI's Insider Trading Regulations. The company addressed non-compliance matters concerning SDD (Structured Digital Database) requirements that affected three consecutive quarters.

Compliance Issues Identified

The board discussed non-compliance with provisions of Regulation 3(5) and/or Regulation 3(6) of SEBI (Prohibition of Insider Trading) Regulations, 2015. The compliance issues specifically related to the following quarters:

Nature of Non-Compliance

According to the board's statement, the company was required to submit SDD certificates duly certified by a Practicing Company Secretary as per Exchange Circular No. 20241018-44 dated October 18, 2024. However, the company inadvertently submitted SDD certificates without the required Practicing Company Secretary certification for all three quarters.

The board acknowledged this inadvertent omission and expressed sincere regret for the oversight. The directors emphasized that this was an unintentional error rather than a deliberate violation of regulatory requirements.

Remedial Actions Taken

The company's secretarial team has implemented corrective measures to address the compliance gaps:

• Resubmitted SDD certificates with proper Practicing Company Secretary certification on December 1, 2025
• Additional submission made on January 3, 2026
• All three affected quarters (March 31, 2025, June 30, 2025, and September 30, 2025) have been addressed

Board's Commitment to Compliance

The Board of Directors made several commitments regarding future compliance:

• Acknowledged the importance of adhering to all regulatory requirements
• Assured that such incidents will not recur in the future
• Committed to taking all necessary steps to ensure adherence to applicable rules and regulations
• Emphasized maintaining the highest standards of compliance
• Expressed commitment to preserving good relationships with the exchange

The board's response demonstrates the company's recognition of the seriousness of regulatory compliance and its commitment to maintaining proper corporate governance standards going forward.